Syncona Ltd
LSE:SYNC

Watchlist Manager
Syncona Ltd Logo
Syncona Ltd
LSE:SYNC
Watchlist
Price: 88 GBX 1.27%
Market Cap: £535.2m

EV/EBITDA

-5.7
Current
11%
More Expensive
vs 3-y median of -5.2

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-5.7
=
Enterprise Value
GBX595.5m
/
EBITDA
£-93.6m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-5.7
=
Enterprise Value
GBX595.5m
/
EBITDA
£-93.6m

Valuation Scenarios

Syncona Ltd is trading above its industry average

If EV/EBITDA returns to its Industry Average (0.1), the stock would be worth GBX-1.62 (102% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-102%
Maximum Upside
No Upside Scenarios
Average Downside
101%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple -5.7 GBX88
0%
Industry Average 0.1 GBX-1.62
-102%
Country Average 0.1 GBX-0.95
-101%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
GBX595.5m
/
Oct 2025
£-93.6m
=
-5.7
Current
GBX595.5m
/
Mar 2026
£226.2m
=
2.6
Forward
GBX595.5m
/
Mar 2027
£256.5m
=
2.3
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
GG
Syncona Ltd
LSE:SYNC
534.9m GBP -5.7 -5.7
US
GE Vernova LLC
NYSE:GEV
267.1B USD 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 3 417.4 4 020.7
NL
Nepi Rockcastle NV
JSE:NRP
98.8B ZAR 14 10.2
US
Fintech Ecosystem Development Corp
NASDAQ:FEXD
66.8B USD -17 660.7 37 715.7
US
CoreWeave Inc
NASDAQ:CRWV
55.4B USD 0 0
CH
Galderma Group AG
SIX:GALD
37.3B CHF 0 0
US
Coupang Inc
F:788
30.7B EUR 31 170.1
US
Symbotic Inc
NASDAQ:SYM
32.9B USD -3 979.6 -3 020.2
ZA
Vukile Property Fund Ltd
JSE:VKE
29B ZAR 17.2 6.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
GG
Syncona Ltd
LSE:SYNC
Average EV/EBITDA: 869.9
Negative Multiple: -5.7
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
71%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
14
7%
2
US
F
Fintech Ecosystem Development Corp
NASDAQ:FEXD
Negative Multiple: -17 660.7 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
111%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
29%
N/A
US
Coupang Inc
F:788
31
49%
0.6
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 979.6 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
17.2
12%
1.4
P/E Multiple
Earnings Growth PEG
GG
Syncona Ltd
LSE:SYNC
Average P/E: 8 384.7
Negative Multiple: -5.7
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10.2
1%
10.2
US
F
Fintech Ecosystem Development Corp
NASDAQ:FEXD
37 715.7
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
47%
N/A
US
Coupang Inc
F:788
170.1
96%
1.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 020.2 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6.7
-5%
N/A

Market Distribution

Lower than 100% of companies in Guernsey
Percentile
0th
Based on 35 companies
0th percentile
-5.7
Low
0 — 0
Typical Range
0 — 0.1
High
0.1 —
Distribution Statistics
Guernsey
Min 0
30th Percentile 0
Median 0.1
70th Percentile 0.1
Max 57.7

Syncona Ltd
Glance View

Syncona Ltd is a GG-based company operating in industry. Syncona Limited is a Guernsey-based closed-ended investment company. The firm is a healthcare company focused on founding, building and funding a portfolio of life science companies. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The firm invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments). Syncona Investment Management Limited (SIML), acts as the Company’s alternative investment fund manager (investment manager).

SYNC Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett